课题基金 / 基金详情

Training Program in Translational Research in Cancer

Training Program in Translational Research in Cancer
癌症转化研究培训计划
批准号:
6783261
负责人:
EDMUND C. LATTIME
金额:
$22.08万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-08-01 至 2008-06-30

项目摘要

项目成果

EDMUND C. LATTIME的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):成功完成转化研究需要将最高质量的基础科学实验室研究与对发现临床转化的独特要求的基本理解相结合。为了实现最有效地将基础发现转化为临床,应该在研究发展的各个层面考虑对这种举措的临床需求的评估,而不是将其作为基础实验室发展的复杂事后考虑。这个翻译研究培训项目的重点就是这种整合。这个博士后培训项目的主要目标是为候选人提供最高质量的培训和研究经验,使他们在学术界、政府和私营部门发展研究事业时具有竞争力。
英文摘要
DESCRIPTION (provided by applicant): The successful accomplishment of translational research requires a combination of the highest quality of basic science laboratory studies with a fundamental understanding of the unique requirements of clinical translation of the discoveries. In order to achieve the most efficient translation of basic findings to the clinic, the appreciation of the clinical requirements of such a move should be considered at all levels of research development rather than as a complicating afterthought to the basic laboratory development. This training program in translational research focuses on just this integration. The primary objective of this postdoctoral training program in translational cancer research is to provide candidates with the highest quality training and research experience so that they will be competitive in developing research careers in academia, government, and the private sector. This program has been designed to train postdoctoral fellows (both M.D. and Ph.D.) in the development and testing of clinically important diagnostic and therapeutic strategies. As the first priority, fellows will be trained in highly critical and successful laboratories to assure the highest level of scientific rigor. In addition, elective courses and seminar discussion series have been designed to focus on the unique requirements for clinical translation of the basic science findings. Postdoctoral fellows will be expected to take part in both the clinically relevant courses and participate in the seminar discussion series. Faculty has been chosen from our ongoing science programs based on: 1. The highest quality of their research; 2. Their translational research activities; and 3. Their commitment to collaborative research in the context of The Cancer Institute of New Jersey (CINJ). All of the preceptors chosen for this program meet these three criteria. Postdoctoral candidates will be either Ph.D. holders who wish to develop careers in clinically relevant research or M.D. (M.D./Ph.D.) finishing their training (following their clinical fellowships) who wish to prepare for careers in academic medicine. Graduates of the postdoctoral program will be expected to be competitive for academic faculty positions and should be competitive for entry level funding awards at the R01 level.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
TAS::75 0849::TAS
TAS::75 0849::TAS
Fluorescence Activated Cell Sorter
TGFBeta Receptor Mutations in Cancer and Other Diseases
海外基金